Drug Shortage Report for BENLYSTA

Last updated on 2018-10-19
Report ID 64584
Drug Identification Number 02370069
Brand name BENLYSTA
Common or Proper name belimumab lyophilized powder for intravenous infusion
Company Name GLAXOSMITHKLINE INC
Active Ingredient(s) BELIMUMAB
Strength(s) 400MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 1x20mL
ATC code L04AA
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-10-12
Estimated end date 2018-10-25
Actual end date 2018-10-18
Shortage status Resolved
Updated date 2018-10-19
Company comments
Health Canada comments
Company contact information 1-800-387-7374